Published in Neurol Clin on November 01, 1990
Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med (2006) 1.32
Cellular mechanisms underlying the pharmacological induction of phosphenes. Br J Pharmacol (2007) 0.99
Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurol Sci (2009) 0.95
Biochemistry of primary headaches: role of tyrosine and tryptophan metabolism. Neurol Sci (2015) 0.90
Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat Outcome Meas (2010) 0.88
Migraine during pregnancy: is it more than a headache? Nat Rev Neurol (2009) 0.87
Understanding the relationship between pain and emotion in idiopathic headaches. Neurol Sci (2013) 0.86
Transcranial magnetic stimulation of visual cortex in migraine patients: a systematic review with meta-analysis. J Headache Pain (2012) 0.85
Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular Disorders. Integr Med Insights (2015) 0.83
Pharmacological targeting of spreading depression in migraine. Expert Rev Neurother (2012) 0.80
Primary visual cortex excitability in migraine: a systematic review with meta-analysis. Neurol Sci (2012) 0.79
Cortical spreading depression: origins and paths as inferred from the sequence of events during migraine aura. Funct Neurol (2014) 0.79
Cortical hyperexcitability in migraine and aversion to patterns. Cephalalgia (2012) 0.79
Central mechanism of action of antimigraine prophylactic drugs. Neurol Sci (2008) 0.78
A 'complex' of brain metabolites distinguish altered chemistry in the cingulate cortex of episodic migraine patients. Neuroimage Clin (2016) 0.78
The efficacy of ginkgolide B in the acute treatment of migraine aura: an open preliminary trial. Neurol Sci (2013) 0.77
Levetiracetam in the preventive treatmentof transformed migraine: A prospective, open-label, pilot study. Curr Ther Res Clin Exp (2005) 0.77
Migraine: an overview. Open Neurol J (2009) 0.77
Pattern glare: the effects of contrast and color. Front Psychol (2015) 0.76
Prevention of Visual Stress and Migraine With Precision Spectral Filters. Drug Dev Res (2007) 0.75
Local therapies in migraine. Neurol Sci (2009) 0.75
Mechanisms of phosphenes in irradiated patients. Oncotarget (2017) 0.75
Perceptive aspects of visual aura. Neurol Sci (2009) 0.75
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol (2001) 3.06
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol (2000) 2.13
The Henry Ford Hospital Headache Disability Inventory (HDI). Neurology (1994) 1.72
Low brain magnesium in migraine. Headache (1989) 1.70
Genetic modulation of oral anticoagulation with warfarin. Thromb Haemost (2000) 1.67
Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial. Lancet (2001) 1.63
MEG localization of language-specific cortex utilizing MR-FOCUSS. Neurology (2004) 1.58
Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol (1998) 1.49
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol (1996) 1.49
Headache in ischemic cerebrovascular disease. Part I: Clinical features. Cephalalgia (1992) 1.41
Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology (2000) 1.27
A randomized study comparing retroperitoneal drainage with no drainage after lymphadenectomy in gynecologic malignancies. Gynecol Oncol (1997) 1.23
Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology (1998) 1.22
The nociceptive flexion reflex in humans -- review article. Pain (2002) 1.21
Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol (2001) 1.21
Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med (1998) 1.20
The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost (1998) 1.13
Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer (2000) 1.13
Headache disability inventory (HDI): short-term test-retest reliability and spouse perceptions. Headache (1995) 1.11
Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost (1999) 1.09
Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry (1993) 1.08
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia (2004) 1.08
Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy. Radiology (1992) 1.06
Pre-surgical planning and MR-tractography utility in brain tumour resection. Eur Radiol (2009) 1.05
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group. Neurology (1997) 1.04
RGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb). J Biol Chem (2001) 1.03
Auditory evoked cortical magnetic field (M100-M200) measurements in tinnitus and normal groups. Hear Res (1991) 1.03
Significance of epidermal growth factor receptor expression in primary human endometrial cancer. Int J Cancer (1994) 1.02
A new vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with decreased stability of CYP2C9 enzyme. J Thromb Haemost (2006) 0.99
Central neurogenic mechanisms of migraine. Neurology (1993) 0.95
Multi-Resolution FOCUSS: a source imaging technique applied to MEG data. Brain Topogr (2005) 0.94
Acute confusional migraine: clinical and electroencephalographic aspects. Cephalalgia (1987) 0.94
Why do we need NIRS in migraine? Neurol Sci (2007) 0.93
Perfusion CT in solid body-tumours. Part II: Clinical applications and future development. Radiol Med (2010) 0.92
Low brain magnesium in migraine. Headache (1989) 0.91
Brain metastasis from prostate cancer. Report of 13 cases and critical analysis of the literature. J Exp Clin Cancer Res (2005) 0.90
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma. Clin Cancer Res (2001) 0.90
Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia (1995) 0.88
NMR spectroscopic and magnetoencephalographic studies in migraine with aura: support for the spreading depression hypothesis. Pathol Biol (Paris) (1992) 0.88
Platelet activation and analysis of organelles in migraineurs. Headache (1989) 0.88
CT perfusion in solid-body tumours. Part I: Technical issues. Radiol Med (2010) 0.88
Effect of therapy on platelet activating factor-induced aggregation in acute stroke. Stroke (1989) 0.87
Magnetoencephalographic studies of migraine. Headache (1990) 0.87
Intra- and interobserver agreement and impact of arterial input selection in perfusion CT measurements performed in squamous cell carcinoma of the upper aerodigestive tract. AJNR Am J Neuroradiol (2009) 0.87
Magnetic resonance spectroscopy in cerebral ischemia. Neurol Clin (1992) 0.87
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer. Ann Oncol (2011) 0.87
Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol (1999) 0.87
Life-style in patients with LUTS suggestive of BPH. Eur Urol (2001) 0.86
Diagnosis of migraine: empirical analysis of a large clinical sample of atypical migraine (IHS 1.7) patients and proposed revision of the IHS criteria. Cephalalgia (2001) 0.86
Magnetic fields associated with spreading depression in anaesthetised rabbits. Brain Res (1991) 0.85
Role of magnetic resonance tractography in the preoperative planning and intraoperative assessment of patients with intra-axial brain tumours. Radiol Med (2007) 0.84
Mitochondria, magnesium and migraine. J Neurol Sci (1995) 0.84
Peroxidase-labelling of human serum transferrin by conjugation to oligosaccharide moieties. Clin Chim Acta (1998) 0.84
Treatment of hirsutism with myo-inositol: a prospective clinical study. Reprod Biomed Online (2008) 0.84
Platelet activity in migraine. Headache (1982) 0.84
Cerebral blood flow changes with enalapril. Pharmacotherapy (1992) 0.83
Platelet activity in cluster headache. Cephalalgia (1986) 0.83
Ovarian steroid levels in migraine with and without aura. Cephalalgia (1990) 0.83
Different patterns of human serum transferrin on isoelectric focusing using synthetic carrier ampholytes or immobilized pH gradients. Electrophoresis (1988) 0.83
Stress and other psychosocial characteristics of patients with psychogenic nonepileptic seizures. Psychosomatics (2000) 0.83
Meningeal enhancement and low CSF pressure headache. An MRI study. Cephalalgia (1991) 0.83
The role of neurotransmitters in the genesis of uremic encephalopathy. Int J Artif Organs (1984) 0.83
Neuromagnetic fields in migraine: preliminary findings. Cephalalgia (1990) 0.82
Analysis of MEG signals of spreading cortical depression with propagation constrained to a rectangular cortical strip. II. Gyrencephalic swine model. Brain Res (1999) 0.82
Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ib alpha gene in a patient with a severe bleeding tendency. Thromb Haemost (1999) 0.82
Neurogenic inflammation in primary headaches. Neurol Sci (2003) 0.82
Migraine with aura triggered by orgasm. Cephalalgia (2002) 0.82
ICA methods for MEG imaging. Neurol Clin Neurophysiol (2004) 0.81
Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology (1989) 0.81
Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents. Stroke (1989) 0.81
Cytosolic ionized calcium homeostasis in platelets: an abnormal sensitivity to PAF-activation in migraine. Headache (1988) 0.81
Electrophoretic detection of ascorbate oxidase activity by photoreduction of nitroblue tetrazolium. Anal Biochem (1990) 0.81
Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies--prevalence and significance. Thromb Haemost (1998) 0.80
Two dimensional inverse imaging (2DII) of current sources in magnetoencephalography. Brain Topogr (2000) 0.80
Binding of various ovotransferrin fragments to chick-embryo red cells. Biochem J (1989) 0.80
Multiple sclerosis and gliomas. Clinical remarks on 10 cases and critical review of the literature. J Neurosurg Sci (2004) 0.79
Emerging trends in the pharmacotherapy of chronic pain. Expert Opin Investig Drugs (2003) 0.79
Deep intronic variations may cause mild hemophilia A. J Thromb Haemost (2011) 0.79
Sensory and motor neuropathy caused by excessive ingestion of vitamin B6: a case report. Funct Neurol (1994) 0.79
Characterization of naturally occurring cutaneous neurofibromatosis in Holstein cattle. A disorder resembling neurofibromatosis type 1 in humans. Am J Pathol (1994) 0.79
Usefulness of image guidance in the surgical treatment of petrous apex cholesterol granuloma. Case Rep Otolaryngol (2013) 0.79
Nimodipine versus flunarizine in common migraine: a controlled pilot trial. Headache (1987) 0.79
Cerebral blood flow in chronic posttraumatic headache. Headache (1997) 0.79
Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer. Gynecol Oncol (1994) 0.79
Uremic encephalopathy: an updating. Clin Nephrol (1986) 0.78
High-dose radiation-induced meningioma in children - case report and critical review of the literature. Zentralbl Neurochir (2005) 0.78
Evidences that zidovudine (AZT) could not be directly responsible for iron overload in AZT-treated patients: an in vitro study. Clin Chim Acta (2000) 0.78
Platelet-activating factor and red blood cells. Thromb Res (1989) 0.78
How to set up a microsurgical laboratory on small animal models: organization, techniques, and impact on residency training. Neurosurg Rev (2008) 0.78
Thiamine intestinal transport and phosphorylation : a study in vitro of potential inhibitors of small intestinal thiamine-pyrophosphokinase using a crude enzymatic preparation. Arch Int Physiol Biochim (1979) 0.78
Serotonergic hypofunction in migraine: a synthesis of evidence based on platelet dense body dysfunction. Cephalalgia (1989) 0.78
Analysis of MEG signals of spreading cortical depression with propagation constrained to a rectangular cortical strip. I. Lissencephalic rabbit model. Brain Res (1999) 0.78
Baseline and activated platelet cytoplasmic ionized calcium in acute ischemic stroke. Effect of aspirin. Stroke (1988) 0.78
Primary leptomeningeal melanomatosis: early leptomeningeal enhancement on MRI. J Neurosurg Sci (2001) 0.78
Sensitivity to PAF is increased in migraine patients. Thromb Haemost (1987) 0.78
Study of platelet activation in migraine: control by low doses of aspirin. Stroke (1984) 0.78